Results 141 to 150 of about 1,862,216 (244)

Identification of endothelial protein C receptor as a novel druggable agonistic target for reendothelialization promotion and thrombosis prevention of eluting stent

Bioactive Materials
The commercially available drug-eluting stent with limus (rapamycin, everolimus, etc.) or paclitaxel inhibits smooth muscle cell (SMC), reducing the in-stent restenosis, whereas damages endothelial cell (EC) and delays stent reendothelialization ...
Jing Chen, Changyi Zhou, Weilun Fang, Jiasheng Yin, Jian Shi, Junbo Ge, Li Shen, Shi-Ming Liu, Shao-Jun Liu   +8 more
doaj   +1 more source

Lateral Mucosal Flap With Steroid‐Eluting Implant in Revision Draf Type III Frontal Sinus Surgery

The Laryngoscope, Volume 136, Issue 9, Page 3732-3736, September 2026.
This technical note introduces a novel endoscopic strategy that integrates a laterally based endonasal mucosal flap with a bioabsorbable steroid‐eluting implant to prevent restenosis following revision of Draf type III frontal sinus surgery. The vascularized flap is stabilized and maintained in close apposition to the underlying bone by a self ...
Mario Turri‐Zanoni, Gloria Schiavo, Marco Valentini, Andrea Presta, Federico Russo, Alessandro Vinciguerra, Paolo Battaglia   +6 more
wiley   +1 more source

Advances in drug eluting stents – focus on the Endeavor® zotarolimus stent

, 2008
Jonathan Bridges, Donald CutlipBeth Israel Deaconess Medical Center, Boston, Massachusetts, USAAbstract: Coronary artery disease remains one of the leading causes of death in the United States.
Jonathan Bridges, Donald Cutlip
core  

Impact of Preoperative Cardiac Screening Modality on Cardiovascular Outcomes After Liver Transplantation

Clinical Transplantation, Volume 40, Issue 9, September 2026.
ABSTRACT Introduction Cardiovascular (CV) disease is a leading cause of morbidity and mortality after liver transplantation (LT). Coronary computed tomography angiography (CCTA) has increasingly replaced stress testing (ST) for CV risk assessment in LT candidates with intermediate‐to‐high CV risk, although comparative evidence remains limited.
Giuseppe Esposito, Marcella Manicardi, Niccolò Bonini, Stefano Di Sandro, Marco Vitolo, Fabrizio Di Benedetto, Giuseppe Boriani, Gian Piero Guerrini   +7 more
wiley   +1 more source

Drug Eluting Stent: A Promising Drug Delivery System

, 2009
TDrug eluting stent is a topic of current interest in the design of drug delivery systems. Drug-eluting stents deliver potentially high doses of drugs locally for variable time periods in the area of stent implantation, directed at the potential ...
Rakesh Patel, Chetan Borkhataria, Samir Patel   +2 more
core   +1 more source

Drug-Eluting Balloon: An Overview of Clinical Evidences on Safety and Effectiveness

Journal of Pharmacoeconomics and Pharmaceutical Management, 2015
Background: Recent advances in the intravascular diseases have led to the entrance of drug-eluting balloon (DEB) technology. The DEB is a relatively new and easier way to treat vascular stenosis.
Khosro Keshavarz, Amir Hashemi-Meshkini, Pardis Zaboli, Jamal Khedmati, Abbas Kebriaeezadeh   +4 more
doaj  

AI‐Assisted Literature Mining Reveals Spatiotemporal Heterogeneity and Progression Trajectories of Traditional Chinese Medicine Syndromes in Coronary Heart Disease in China

Journal of Evidence-Based Medicine, Volume 19, Issue 3, September 2026.
ABSTRACT Despite the centrality of syndrome differentiation in guiding personalized traditional Chinese medicine (TCM) interventions for coronary heart disease (CHD), existing studies of TCM syndrome distribution are constrained by fragmented methodologies and limited spatiotemporal resolution. In this study, we employed an artificial intelligence (AI)‐
Qianzi Che, Tian Song, Zhaoyuan Gong, Chuxuan Wang, Bin Liu, Mingzhi Hu, Ning Liang, Haili Zhang, Huizhen Li, Qingyang Zeng, Lin Chen, Yuanming Leng, Xihao Cao, Jing Wan, Jing Guo, Nannan Shi   +15 more
wiley   +1 more source

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)

, 2008
Imad Sheiban1, Gianluca Villata1, Mario Bollati1, Dario Sillano1, Marzia Lotrionte2, Giuseppe Biondi-Zoccai11Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy; 2Institute of Cardiology, Catholic University, Rome ...
Gianluca Villata, Mario Bollati, Giuseppe Biondi-Zoccai, Imad Sheiban, Marzia Lotrionte, Dario Sillano   +5 more
core  

Biodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical results

, 2014
Guillaume Schurtz,1,2 Cédric Delhaye,1 Christopher Hurt,1,2 Henri Thieuleux,1,2 Gilles Lemesle1–3 1Centre Hémodynamique et Unité des Soins Intensifs de Cardiologie, Hôpital Cardiologique, Centre Hospitalier Ré ...
Hurt C, Schurtz G, Thieuleux H, Lemesle G, Delhaye C   +4 more
core  

Drug-eluting stents : Insights into safety and indications

Annals of Saudi Medicine, 2008
Currently, more than 4 million patients receive drug-eluting stents worldwide. Despite recent studies and editorials that have stirred controversy and generated tremendous publicity in the lay press related to the safety of drug-eluting stents for the ...
Hassan Walid
doaj